Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Malmo – page 100

1 356 clinical trials in Malmo, Sweden across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Malmo at a glance
1 356
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

1 356 trials in Malmo

Open in trial search

Malignant melanoma

Not recruiting

Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:MRNA-4157
  • Sponsor:Merck Sharp & Dohme LLC

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on the Effects of Colchicine for Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Gentofte Hospital

Breast cancer stage III+3

Not recruiting

Study on Preoperative Treatment for HER2 Positive Breast Cancer Using Docetaxel, Pertuzumab, and Trastuzumab in Patients with Primary Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Karolinska University Hospital

Long-term Safety Study of Mavacamten for Adults with Hypertrophic Cardiomyopathy from Previous Trials

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
  • Sponsor:Myokardia Inc.

COVID-19

Not recruiting

Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:University Of Minnesota

Lichen sclerosus

Not recruiting

Study on the Effectiveness and Safety of MC2-25 Cream for Women with Vulvar Lichen Sclerosus

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alanyl Glutamine
  • Sponsor:Mc2 Therapeutics Limited

Major depression

Not recruiting

Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine
  • Sponsor:Compass Pathfinder Limited

Study on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Brentuximab Vedotin
  • Sponsor:Seagen Inc.

Renal failure+1

Not recruiting

Study on Dapagliflozin for Kidney Protection in Heart Transplant Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Oslo Universitetssykehus HF

Plasma cell myeloma

Not recruiting

Study on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:F. Hoffmann-La Roche AG

Study Comparing Ibrutinib and Venetoclax with Chlorambucil and Obinutuzumab for First-line Treatment in Patients with Chronic Lymphocytic Leukemia

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Janssen Cilag International

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Malmo

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on metastatic prostate cancer treatments and breakthrough therapies for colorectal cancer. Research includes studies of novel drug combinations and targeted therapies for breast cancer patients.

  • Advanced prostate cancer treatments
  • Colorectal cancer interventions
  • Breast cancer therapy optimization
02 Neurodegenerative Disorders

Comprehensive studies on Alzheimer's disease diagnostics and treatment, including innovative research on ALS therapies. Investigations utilize advanced imaging techniques and novel therapeutic approaches.

  • Early Alzheimer's intervention
  • ALS treatment development
  • Cognitive disorder diagnostics
03 Metabolic and Chronic Conditions

Trials examining treatments for obesity and type 2 diabetes, along with innovative approaches to managing chronic kidney disease. Research focuses on biomarker-targeted treatments and lifestyle interventions.

  • Weight management therapies
  • Diabetes treatment optimization
  • Kidney disease interventions
04 Infectious Diseases

Studies evaluating vaccines for respiratory syncytial virus, HPV, and Herpes Zoster. Research aims to prevent viral infections and improve vaccination strategies in various age groups.

  • Viral infection prevention
  • Vaccine effectiveness studies
  • Immunization programs
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.